The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 31, 2024

Filed:

Sep. 16, 2022
Applicant:

Principia Biopharma Inc., Bridgewater, NJ (US);

Inventors:

Steven Gourlay, Queens Park, AU;

Ann Neale, Danville, CA (US);

Philip Nunn, Mountain View, CA (US);

Claire Langrish, Redwood City, CA (US);

Olga Bandman, Mountain View, CA (US);

Dolca Thomas, San Francisco, CA (US);

Assignee:

Principia Biopharma Inc., Bridgewater, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); A61K 9/00 (2006.01); A61K 9/28 (2006.01); A61K 45/06 (2006.01); A61P 7/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 9/0053 (2013.01); A61K 9/28 (2013.01); A61P 7/00 (2018.01); A61K 45/06 (2013.01);
Abstract

Methods for treating immune thrombocytopenia comprising administering at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile (PRN1008) and pharmaceutically acceptable salts thereof are disclosed. Pharmaceutical compositions comprising at least one compound chosen from PRN1008 and pharmaceutically acceptable salts thereof are also disclosed.


Find Patent Forward Citations

Loading…